Special Report: You Could Lose or Make a Fortune

Sushree Mohanty

Sushree Mohanty


Recent articles

Aurora Cannabis rebound

Can Aurora Cannabis Stock Rebound in 2020?

Has this Canadian pot company done enough to convince investors that it can come back from its disastrous 2019?

Bristol Myers Squibb

Is Bristol Myers Squibb Stock a Buy?

Here’s why choosing this pharma stock amid the coronavirus crisis could be the wisest decision you make this year.

Marijuana stock

Better Cannabis Stock: Canopy Growth or Aurora Cannabis?

Among these two popular players in the Canadian cannabis space, which is a better option for 2020?

Charlotte's Web

Is Charlotte's Web Stock a Buy?

With U.S. cannabis companies in the limelight this year, here is what to consider with this CBD stock.

Cannabis companies

Better Cannabis Stock: Green Thumb Industries or Charlotte's Web?

The U.S. marijuana industry looks promising, but which of these two pot stocks should you choose?

Cannabis stocks

3 Top Cannabis Stocks to Buy Right Now

If the marijuana sector has sparked your interest lately, these three pot stocks are for you.

Covid-19 vaccine

Is Moderna Stock a Buy?

This biotech company is hard at work to win the coronavirus vaccine race. Will it succeed?


Better Cannabis Stock: Cronos or Charlotte's Web?

One is Canada-based, the other is in the U.S. Which is the better bet?

Marijuana stocks

Better Buy: GW Pharmaceuticals vs. Corbus Pharmaceuticals

What’s the choice between these U.K and U.S. biotech-cannabis companies?


Is HEXO Stock a Buy?

After receiving a warning about possible delisting from the NYSE, this cannabis company is trying to rebuild itself. Will it succeed?

Cannabis stocks

Better Buy: Aurora Cannabis vs. Cronos Group

One has seen a roller-coaster ride and is now rising from the ashes; the other has always played it safe. Which pot stock is a better bet?

Cannabis companies expansion plans

2 Cannabis Stocks Planning to Expand During the Coronavirus Pandemic

While Canadian peers are struggling to hit profitability, these two U.S. pot companies are planning expansion amid COVID-19.

Medical versus Recreational marijuana

Medical vs. Recreational Cannabis: Which Is the Future?

Both cannabis markets are drawing attention. How are these two companies approaching these segments?

Trulieve Cannabis

3 Reasons Why It's the Right Time to Buy Trulieve Cannabis

Its dominance in one state and staggering growth from just medical cannabis show its potential to thrive, but there could be some risk.

Cannabis 2.0 products

Can Cannabis 2.0 Products Boost Canopy Growth and Organigram in 2020?

Will the potential of cannabis derivatives products push these two cannabis companies towards growth this year?

Acreage Holdings

Acreage Holdings Q1 Results Disappoint: Will the Amended Deal with Canopy Growth Help?

Growing concerns in the U.S. pot market forced Canopy Growth to amend the deal with Acreage as the latter reported disappointing Q1 earnings. Will the new arrangement help Acreage's stock?

Aurora Cannabis

Are Good Times Coming for Aurora Cannabis?

After an unanticipated third quarter, this pot company is making some hard decisions. Will the efforts pay off?


These 2 Pot Stocks Are Winning the Most From New Legal Cannabis Markets

The Illinois cannabis market is booming, and so is the revenue growth for these two pot companies.


Why Innovative Industrial Properties Is the Best REIT Pot Stock

A favorite REIT/pot stock in 2019 is working wonders in 2020.

Acreage Holdings

Should You Buy Acreage Holdings?

The cannabis company's speculative acquisition deal with Canopy Growth isn't the only reason to like this stock.